Dr Jocelyn Nichole Spoon, MD | |
500 W Broadway St, Suite 320, Missoula, MT 59802-4008 | |
(406) 329-5615 | |
(406) 329-2791 |
Full Name | Dr Jocelyn Nichole Spoon |
---|---|
Gender | Female |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 17 Years |
Location | 500 W Broadway St, Missoula, Montana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548427644 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
St. Patrick Hospital | Missoula, MT | Hospital |
Clark Fork Valley Hospital | Plains, MT | Hospital |
Steele Memorial Medical Center | Salmon, ID | Hospital |
Providence St Joseph Medical Center | Polson, MT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Providence Health And Services Mt | 6608786306 | 272 |
News Archive
Scientists in Sydney and Boston believe they may have identified a gene that controls abnormal production of sugar in the liver, a very troublesome problem for people with diabetes.
...according to new data released today by the Substance Abuse and Mental Health Services Administration (SAMHSA). The data show that pregnant women ages 15 to 25 were more likely to use illicit drugs than pregnant women ages 26 to 44.
WaveMark, Inc., a leading provider of real-time inventory management (RTIM) solutions for high value medical products, and St. Joseph's Hospital of Atlanta, GA today announced the use of WaveMark's hospital inventory management solution, WaveMark CIMS™, by St. Joseph's Hospital to manage its high value, specialty inventory. St. Joseph's will use WaveMark's point of use RTIM technology to track physician preference items in its Cardiac Cath and Electrophysiology (EP) labs.
ARMGO Pharma, Inc., a biopharmaceutical company developing innovative small molecule drugs known as "Rycals™," which act on the ryanodine receptor calcium-release channel (RyR), announced that a study published today in the prestigious scientific journal Cell reveals the underlying role of calcium leak through the RyR as an important contributor to stress-induced cognitive dysfunction.
Genzyme, a Sanofi company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the company's resubmission of its supplemental Biologics License Application (sBLA) seeking approval of LemtradaTM (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis.
› Verified 3 days ago
Entity Name | Providence Health & Services Mt |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144319138 PECOS PAC ID: 6608786306 Enrollment ID: O20031229000787 |
News Archive
Scientists in Sydney and Boston believe they may have identified a gene that controls abnormal production of sugar in the liver, a very troublesome problem for people with diabetes.
...according to new data released today by the Substance Abuse and Mental Health Services Administration (SAMHSA). The data show that pregnant women ages 15 to 25 were more likely to use illicit drugs than pregnant women ages 26 to 44.
WaveMark, Inc., a leading provider of real-time inventory management (RTIM) solutions for high value medical products, and St. Joseph's Hospital of Atlanta, GA today announced the use of WaveMark's hospital inventory management solution, WaveMark CIMS™, by St. Joseph's Hospital to manage its high value, specialty inventory. St. Joseph's will use WaveMark's point of use RTIM technology to track physician preference items in its Cardiac Cath and Electrophysiology (EP) labs.
ARMGO Pharma, Inc., a biopharmaceutical company developing innovative small molecule drugs known as "Rycals™," which act on the ryanodine receptor calcium-release channel (RyR), announced that a study published today in the prestigious scientific journal Cell reveals the underlying role of calcium leak through the RyR as an important contributor to stress-induced cognitive dysfunction.
Genzyme, a Sanofi company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the company's resubmission of its supplemental Biologics License Application (sBLA) seeking approval of LemtradaTM (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis.
› Verified 3 days ago
Entity Name | Providence St Joseph Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669655528 PECOS PAC ID: 0446230247 Enrollment ID: O20040910001134 |
News Archive
Scientists in Sydney and Boston believe they may have identified a gene that controls abnormal production of sugar in the liver, a very troublesome problem for people with diabetes.
...according to new data released today by the Substance Abuse and Mental Health Services Administration (SAMHSA). The data show that pregnant women ages 15 to 25 were more likely to use illicit drugs than pregnant women ages 26 to 44.
WaveMark, Inc., a leading provider of real-time inventory management (RTIM) solutions for high value medical products, and St. Joseph's Hospital of Atlanta, GA today announced the use of WaveMark's hospital inventory management solution, WaveMark CIMS™, by St. Joseph's Hospital to manage its high value, specialty inventory. St. Joseph's will use WaveMark's point of use RTIM technology to track physician preference items in its Cardiac Cath and Electrophysiology (EP) labs.
ARMGO Pharma, Inc., a biopharmaceutical company developing innovative small molecule drugs known as "Rycals™," which act on the ryanodine receptor calcium-release channel (RyR), announced that a study published today in the prestigious scientific journal Cell reveals the underlying role of calcium leak through the RyR as an important contributor to stress-induced cognitive dysfunction.
Genzyme, a Sanofi company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the company's resubmission of its supplemental Biologics License Application (sBLA) seeking approval of LemtradaTM (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jocelyn Nichole Spoon, MD Po Box 12, Liberty Lake, WA 99019-0012 Ph: (406) 327-1918 | Dr Jocelyn Nichole Spoon, MD 500 W Broadway St, Suite 320, Missoula, MT 59802-4008 Ph: (406) 329-5615 |
News Archive
Scientists in Sydney and Boston believe they may have identified a gene that controls abnormal production of sugar in the liver, a very troublesome problem for people with diabetes.
...according to new data released today by the Substance Abuse and Mental Health Services Administration (SAMHSA). The data show that pregnant women ages 15 to 25 were more likely to use illicit drugs than pregnant women ages 26 to 44.
WaveMark, Inc., a leading provider of real-time inventory management (RTIM) solutions for high value medical products, and St. Joseph's Hospital of Atlanta, GA today announced the use of WaveMark's hospital inventory management solution, WaveMark CIMS™, by St. Joseph's Hospital to manage its high value, specialty inventory. St. Joseph's will use WaveMark's point of use RTIM technology to track physician preference items in its Cardiac Cath and Electrophysiology (EP) labs.
ARMGO Pharma, Inc., a biopharmaceutical company developing innovative small molecule drugs known as "Rycals™," which act on the ryanodine receptor calcium-release channel (RyR), announced that a study published today in the prestigious scientific journal Cell reveals the underlying role of calcium leak through the RyR as an important contributor to stress-induced cognitive dysfunction.
Genzyme, a Sanofi company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the company's resubmission of its supplemental Biologics License Application (sBLA) seeking approval of LemtradaTM (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis.
› Verified 3 days ago
Mr. George Bandow, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2809 Great Northern Loop, Suite 200, Missoula, MT 59808 Phone: 406-541-7139 Fax: 406-541-7143 | |
Simone Musco, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 500 W Broadway St, Ste 320, Missoula, MT 59802 Phone: 406-329-5615 | |
Rolf H O Holle, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1782 Elison Ln Unit 3, Missoula, MT 59802 Phone: 406-544-1871 | |
John David Anthony Lakatua, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 500 West Broadway, Missoula, MT 59802 Phone: 406-721-5600 Fax: 406-721-3907 | |
Mr. Curtis G Wickre, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 500 W Broadway St, 4th Floor, Missoula, MT 59802 Phone: 406-327-1900 | |
Dr. Charlotte Nelson, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 500 W Broadway St, Missoula, MT 59802 Phone: 406-327-1613 | |
Michele A Danicich, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 900 N Orange St Ste 304, Missoula, MT 59802 Phone: 406-329-5781 Fax: 406-327-3331 |